| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 29-Mar-09 | 31-Dec-08 | | Total Revenue | 64,976 | 73,586 | 61,446 | 77,397 | | Cost of Revenue | 47,560 | 57,730 | 49,614 | 58,846 | | | Gross Profit | 17,416 | 15,856 | 11,831 | 18,550 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 6,568 | 6,355 | 4,567 | 7,274 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 10,848 | 9,501 | 7,264 | 11,276 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 80 | 9 | 0 | 81 | | Earnings Before Interest And Taxes | 10,928 | 9,510 | 7,264 | 11,358 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 10,928 | 9,510 | 7,264 | 11,358 | | Income Tax Expense | 4,263 | 3,566 | 2,512 | 4,385 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 6,665 | 5,944 | 4,752 | 6,973 | | | Non-recurring Events | | Discontinued Operations |
-
| 109 | 340 |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,665 | 6,053 | 5,092 | 6,973 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $6,665 | $6,053 | $5,092 | $6,973 |
|
0.02% Nasdaq 
Income Statement
